業績

Watanabe-Kusunoki K, Nakazawa D, Yamamoto J, Matsuoka N, Kaneshima N, Nakagaki T, Yamamoto R, Maoka T, Iwasaki S, Tsuji T, Fukasawa Y, Nishimoto N, Nishio S, Atsumi T.

Comparison of administration of single- and triple-course steroid pulse therapy combined with tonsillectomy for immunoglobulin A nephropathy.

Medicine, in press

IF: 1.889

  • 2021
  • 腎臓グループ
  • 欧文論文/原著

Kamoshima H, Nomoto H, Yamashita K, Takahashi Y, Tsuchida K, Kuwabara S, Miya A, Cho KY, Kameda H, Nakamura A, Atsumi T, Taneda S, Kurihara Y, Aoki S, Ono Y, Miyoshi H.

Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?

Endocrine Journal, in press.

IF: 2.349

  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Oba-Yamamoto C, Takeuchi J, Nakamura A, Nomoto H, Kameda H, Cho KY, Atsumi T, Miyoshi H Impact of low-starch high-fiber pasta on postprandial blood glucose.

Nutrition, Metabolism and Cardiovascular Diseases, in press.

IF: 4.222

  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Kawata S, Nakamura A, Miyoshi H, Yang K, Shigesawa I, Yamauchi Y, Tsuchida K, Omori K, Takahashi K, Nomoto H, Kameda H, Cho KY, Terauchi Y, Atsumi T.

Glucokinase activation leads to an unsustained hypoglycaemic effect with hepatic triglyceride accumulation in db/db mice.

Diebetes Obes Metab, in press.

IF: 6.57

  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Sugawara M, Fujieda Y, Noguchi A, Tanimura S, Shimizu Y, Nakagawa I, Yoshimura M, Abe N, Kono M, Kato M, Oku K, Amengual O, Yokota I, Takahashi H, Atsumi T.

Prediction of non-responder to JAK inhibitors in patients with rheumatoid arthritis: a preliminary study with integrative cluster analysis.

Clin Exp Rheumatol. 2021

IF: 3.319

  • 2021
  • 膠原病グループ
  • 欧文論文/原著

Chiba K, Kameda H, Miya A, Nomoto H, Cho KY, Nakamura A, Jin S, Matoba K, Miyoshi H, Atsumi T.

False hypercortisolemia due to abnormal albumin-cortisol binding in a patient with familial dysalbuminemic hyperthyroxinemia.

Thyroid, in press.

IF: 6.568

  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/letter

Nagasaka K, Kaname S, Amano K, Kato M, Katsumata Y, Komagata Y, Sada K, Tanaka E, Tamura N, Dobashi H, Nanki T, Harabuchi Y, Bando M, Homma S, Wada T, Harigai M.

Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour, and Welfare Database.

Modern Rheumatology. in press.

IF: 2.113

  • 2021
  • 膠原病グループ
  • 欧文論文/原著

Usui J, Kawashima S, Sada K, Miyawaki Y, Nakazawa D,.. Narita I, et al.

A digest of the evidence-based Clinical Practice Guideline for Rapidly Progressive Glomerulonephritis 2020.

Clin Exp Nephrol. 2021 Sep 26.  doi: 10.1007/s10157-021-02096-7.

IF: 2.8

  • 2021
  • 腎臓グループ
  • 欧文論文/総説

Kameda R, Cho KY, Nomoto H, Nakamura A, Omori K, Nagai S, Edagawa S, Kawata S, Takeuchi J, Kameda H, Kurihara Y, Aoki S, Atsumi T, Miyoshi H, LUNA Study Investigators.

Lowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: a multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study) Diabetes Research and Clinical Practice, in press.

IF: 5.602

 

  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

令和2年度北海道大学医学部エクセレント・ティーチャー(優秀賞) 中沢 大悟先生

  • 2021
  • 腎臓グループ
  • 受賞